Compounds > gefitinib
Page last updated: 2024-09-03

gefitinib and bisindolylmaleimide iv

gefitinib has been researched along with bisindolylmaleimide iv in 2 studies

Compound Research Comparison

Studies
(gefitinib)		Trials
(gefitinib)		Recent Studies (post-2010)
(gefitinib)		Studies
(bisindolylmaleimide iv)		Trials
(bisindolylmaleimide iv)		Recent Studies (post-2010) (bisindolylmaleimide iv)
5,2315662,9191704

Protein Interaction Comparison

ProteinTaxonomygefitinib (IC50)bisindolylmaleimide iv (IC50)
Serine/threonine-protein kinase D3Homo sapiens (human)0.19
cAMP-dependent protein kinase catalytic subunit alphaBos taurus (cattle)2.955
Protein kinase C gamma typeHomo sapiens (human)0.19
Protein kinase C alpha typeRattus norvegicus (Norway rat)0.325
Protein kinase C beta typeHomo sapiens (human)0.1805
Protein kinase C delta typeRattus norvegicus (Norway rat)0.325
Protein kinase C epsilon typeRattus norvegicus (Norway rat)0.325
Protein kinase C zeta typeRattus norvegicus (Norway rat)0.325
Cyclin-dependent kinase 4Homo sapiens (human)5.81
Protein kinase C alpha typeHomo sapiens (human)0.8945
Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoformOryctolagus cuniculus (rabbit)3.2
G1/S-specific cyclin-D1Homo sapiens (human)5.81
Protein kinase C eta typeHomo sapiens (human)0.19
G1/S-specific cyclin-E1Homo sapiens (human)5.81
Cyclin-dependent kinase 2Homo sapiens (human)5.81
cAMP-dependent protein kinase catalytic subunit alpha Rattus norvegicus (Norway rat)2.55
Protein kinase C iota typeHomo sapiens (human)0.19
Protein kinase C gamma typeRattus norvegicus (Norway rat)0.4
Protein kinase C beta typeRattus norvegicus (Norway rat)0.4
Protein kinase C epsilon typeHomo sapiens (human)3.853
Protein kinase C theta typeHomo sapiens (human)0.19
Protein kinase C zeta typeHomo sapiens (human)0.19
Protein kinase C delta typeHomo sapiens (human)0.19
Calcium/calmodulin-dependent protein kinase type II subunit deltaHomo sapiens (human)1.19
Serine/threonine-protein kinase D1Homo sapiens (human)0.19
Protein kinase C eta typeRattus norvegicus (Norway rat)0.325
NAD-dependent protein deacetylase sirtuin-2Homo sapiens (human)4.7
Protein kinase C theta typeRattus norvegicus (Norway rat)0.325

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Bharate, SB; Raghuvanshi, R1

Other Studies

2 other study(ies) available for gefitinib and bisindolylmaleimide iv

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections.
    Journal of medicinal chemistry, 2022, 01-27, Volume: 65, Issue:2

    Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Repositioning; High-Throughput Screening Assays; Humans; Protein Kinase Inhibitors; SARS-CoV-2; United States; United States Food and Drug Administration; Virus Diseases

2022